| Literature DB >> 34275877 |
Webster Mavhu1,2, Melissa Neuman3, Karin Hatzold4, Stephen Buzuzi5, Galven Maringwa5, Sungai T Chabata5, Collin Mangenah5, Noah Taruberekera6, Ngonidzashe Madidi6, Malvern Munjoma6, Getrude Ncube7, Sinokuthemba Xaba7, Owen Mugurungi7, Cheryl C Johnson8, Elizabeth L Corbett9, Helen A Weiss3, Katherine Fielding3, Frances M Cowan5,2.
Abstract
INTRODUCTION: Reaching men aged 20-35 years, the group at greatest risk of HIV, with voluntary medical male circumcision (VMMC) remains a challenge. We assessed the impact of two VMMC demand creation approaches targeting this age group in a randomised controlled trial (RCT).Entities:
Keywords: HIV; health services research; public health; randomised control trial
Mesh:
Year: 2021 PMID: 34275877 PMCID: PMC8287600 DOI: 10.1136/bmjgh-2021-006141
Source DB: PubMed Journal: BMJ Glob Health ISSN: 2059-7908
Figure 1Primary outcome and secondary outcomes (ii)–(vii). HIVST, HIV self-testing; IPC, interpersonal communication; VMMC, voluntary medical male circumcision.
Figure 2CONSORT diagram for as-treated analysis population. HCD, human-centred design; IPC, interpersonal communication; SOC standard of care; ST self-testing.
Characteristics of IPC agents by arm (as-treated analysis population)
| Arm 1: SOC | Arm 2: ST | Arm 3: HCD | Arm 4: HCD+ST | |||||
| n | % | n | % | n | % | n | % | |
| IPC agents | 29 | 27 | 27 | 22 | ||||
| Total IPC mobilisation—months | 126 | 96 | 101 | 97 | ||||
| Male | 8 | 27.6 | 17 | 63.0 | 15 | 55.6 | 8 | 36.4 |
| District | ||||||||
| Buhera | 6 | 20.7 | 8 | 29.6 | 2 | 7.4 | 9.1 | |
| Gokwe North | 4 | 13.8 | 9 | 33.3 | 4 | 14.8 | 40.9 | |
| Mangwe | 4 | 13.8 | 1 | 3.7 | 3 | 11.1 | 13.6 | |
| Mutasa | 5 | 11.1 | 3 | 11.1 | 11 | 40.7 | 31.8 | |
| Zvimba | 10 | 34.5 | 6 | 22.2 | 7 | 25.9 | 4.6 | |
| Age (years) | ||||||||
| ≤19 | 1 | 3.5 | 1 | 3.7 | 4 | 14.8 | 1 | 4.6 |
| 20–29 | 4 | 13.8 | 12 | 44.5 | 6 | 22.2 | 5 | 22.7 |
| 30–39 | 7 | 24.1 | 8 | 29.6 | 4 | 14.8 | 2 | 9.1 |
| 40–49 | 9 | 31.0 | 5 | 18.5 | 9 | 33.4 | 13 | 59.0 |
| 50+ | 8 | 27.6 | 1 | 3.7 | 4 | 14.8 | 1 | 4.6 |
| Educational level | ||||||||
| Primary level | 8 | 27.6 | 1 | 3.7 | 1 | 3.7 | 0 | 0 |
| Secondary level | 15 | 51.7 | 23 | 85.2 | 25 | 92.6 | 22 | 100 |
| ≥Advanced level | 6 | 20.7 | 3 | 11.1 | 1 | 3.7 | 0 | 0 |
| IPC experience | ||||||||
| <12 months | 22 | 75.9 | 18 | 66.7 | 21 | 77.8 | 9 | 40.9 |
| ≥12 months | 7 | 24.1 | 9 | 33.3 | 6 | 22.2 | 3 | 59.1 |
| Mean/median IPC mobilisation months | 4.2/4 | 3.7/4 | 3.8/3 | 4.4/5 | ||||
HCD, human-centred design; IPC, interpersonal communication; SOC, standard of care; ST, self-testing.
Characteristics of ≥15-year-olds clients reached by arm (as-treated analysis population)
| Arm 1: SOC | Arm 2: ST | Arm 3: HCD | Arm 4: HCD+ST | |||||
| n | % | n | % | n | % | n | % | |
| Total | 3105 | 100 | 1754 | 100 | 2306 | 100 | 1542 | 100 |
| Age in years | ||||||||
| 15–17 | 1102 | 35.5 | 592 | 33.8 | 886 | 38.4 | 509 | 33.0 |
| 18–19 | 571 | 18.4 | 318 | 18.1 | 523 | 22.7 | 278 | 18.0 |
| 20–29 | 952 | 30.7 | 440 | 25.1 | 627 | 27.2 | 558 | 36.2 |
| 30+ | 480 | 15.4 | 404 | 23.0 | 270 | 11.7 | 197 | 12.8 |
| Median age (min-max), years | 19.0 | (15-78) | 19.0 | (15-87) | 18.0 | (15-84) | 19.0 | (15-83) |
| Education completed* | ||||||||
| School-going | 1232 | 40.1 | 638 | 39.6 | 728 | 31.8 | 477 | 31.5 |
| Out of school | 1841 | 59.9 | 1041 | 60.4 | 1560 | 68.2 | 1039 | 68.5 |
*106 missing.
HCD, human-centred design; SOC, standard of care; ST, self-testing.
Figure 3Effect of HCD-informed intervention—as-treated analysis population. HCD, human-centred design; VMMC, voluntary medical male circumcision.
Figure 4Effect of ST intervention—as-treated analysis population. ST, self-testing; VMMC, voluntary medical male circumcision.
Uptake of HIVST, by study arm (ST vs HCD+ST)
| Arm 2: ST | Arm 4: HCD+ST | Effect of HCD+ST vs ST | ||||
| n/N | % | n/N | % | OR (95% CI) | P value | |
| Men offered HIVST (% surveyed) | 129/173 | 74.6 | 71/110 | 64.6 | 0.62 (0.37 to 1.04) | 0.072 |
| Men accepting HIVST (% offered) | 101/129 | 78.3 | 52/71 | 73.2 | 0.76 (0.39 to 1.49) | 0.420 |
| Men using HIVST (% accepted) | 91/101 | 90.1 | 50.52 | 96.2 | 2.75 (0.58 to 13.03) | 0.203 |
| Reactive HIVST (% used) | 5/91 | 5.5 | 1/50 | 2.0 | 0.37 (0.04 to 3.30) | 0.376 (0.072)* |
| Men with reactive test linked to care (% reactive) | 2/5 | 40.0 | 1/1 | 100.0 | ||
*Fisher’s exact test.
HCD, human-centred design; HIVST, HIV self-testing; ST, self-testing.